After three years of development, a smart insole designed by researchers at the University of Malta is showing promising ...

FibroBiologics and Charles River have announced the completion of FibroBiologics’ master cell bank for a product that will be evaluated for the treatment of diabetic foot ulcers and other chronic ...

The future of wearable foot technology is promising, however. Devices are becoming smaller, more affordable and easier to use ...

Cell Analysis of Debrided Diabetic Foot Ulcers Reveals Dysregulated Wound Healing Environment in Non-Hispanic Black Patients,” published in the March 2025 issue of Journal of Investigative Dermatology ...

FibroBiologics, Inc. (NASDAQ:FBLG) is continuing preparations for a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product candidate, in patients suffering from diabetic foot ulcers (DFUs ...

BiomX’s acquisition of Adaptive Phage Therapeutics is looking like a good bet now that one of the treatments from the deal ...

The average plasma fibrinogen level was 681 ± 160 mg/dL, exceeding the normal range. Fibrinogen levels increased with ulcer severity, measuring 503.51 mg/dL for Wagner Grade 2, 623.45 mg/dL for Grade ...

Discover evidence-based strategies for healing diabetic wounds, from immediate care steps to advanced treatments, nutritional ...

Having diabetes has serious consequences for health and is associated with increased risk of developing diseases related to ...